On February 1, 2023, Nicola Heffron, Chief Operating Officer of 2seventy bio, Inc. notified the Company of her intent to resign as Chief Operating Officer of the Company effective as of March 10, 2023. Ms. Heffron's decision to resign was not due to any disagreement with the Company on any matter, or relating to its operations, policies, or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.22 USD | -3.21% | -6.43% | -1.17% |
05-08 | Earnings Flash (TSVT) 2SEVENTY BIO Reports Q1 Revenue $12.4M, vs. Street Est of $14.1M | MT |
05-08 | Transcript : 2seventy bio, Inc., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.17% | 217M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- TSVT Stock
- News 2seventy bio, Inc.
- 2Seventy Bio, Inc Announces Resignation of Nicola Heffron as Chief Operating Officer, Effective as of March 10, 2023